Lineage Cell Therapeutics, Inc. Loans Payable, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Loans Payable, Current of $523.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2022-03-10
- 2021-03-31: Loans Payable, Current $523.00K.
- 2020-12-31: Loans Payable, Current $523.00K.
- 2020-09-30: Loans Payable, Current $523.00K.
- 2020-06-30: Loans Payable, Current $523.00K.
| Period end | Loans Payable, Current |
|---|---|
| 2021-03-31 | $523.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $523.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $523.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $523.00K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |